Neogen Co. (NASDAQ:NEOG) Shares Purchased by American Capital Advisory LLC

American Capital Advisory LLC raised its stake in Neogen Co. (NASDAQ:NEOG) by 291.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 53,213 shares of the company’s stock after purchasing an additional 39,623 shares during the period. American Capital Advisory LLC’s holdings in Neogen were worth $646,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. KBC Group NV grew its position in shares of Neogen by 39.1% in the 4th quarter. KBC Group NV now owns 8,464 shares of the company’s stock valued at $103,000 after buying an additional 2,379 shares during the last quarter. Blue Trust Inc. boosted its stake in Neogen by 196.7% in the fourth quarter. Blue Trust Inc. now owns 3,368 shares of the company’s stock valued at $41,000 after acquiring an additional 2,233 shares in the last quarter. Inspire Investing LLC grew its holdings in shares of Neogen by 30.9% during the fourth quarter. Inspire Investing LLC now owns 36,383 shares of the company’s stock worth $442,000 after purchasing an additional 8,580 shares during the last quarter. Avanza Fonder AB acquired a new stake in shares of Neogen during the fourth quarter worth about $169,000. Finally, Procyon Advisors LLC lifted its holdings in shares of Neogen by 22.3% in the 4th quarter. Procyon Advisors LLC now owns 35,513 shares of the company’s stock valued at $431,000 after purchasing an additional 6,467 shares during the last quarter. Institutional investors and hedge funds own 96.73% of the company’s stock.

Analyst Ratings Changes

Several research firms have commented on NEOG. Guggenheim began coverage on Neogen in a research report on Thursday, December 19th. They set a “buy” rating and a $15.00 price target on the stock. Piper Sandler reaffirmed a “neutral” rating and issued a $13.00 target price (down from $16.50) on shares of Neogen in a report on Tuesday, January 21st.

Insider Activity

In other Neogen news, CFO David H. Naemura bought 14,800 shares of Neogen stock in a transaction on Thursday, January 16th. The stock was bought at an average price of $11.11 per share, with a total value of $164,428.00. Following the completion of the acquisition, the chief financial officer now owns 61,434 shares in the company, valued at $682,531.74. The trade was a 31.74 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO John Edward Adent purchased 23,035 shares of the stock in a transaction dated Thursday, January 16th. The shares were bought at an average cost of $11.03 per share, for a total transaction of $254,076.05. Following the completion of the purchase, the chief executive officer now owns 269,164 shares in the company, valued at approximately $2,968,878.92. This trade represents a 9.36 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 1.13% of the company’s stock.

Neogen Trading Down 2.8 %

Shares of NEOG opened at $10.37 on Friday. The company has a current ratio of 3.77, a quick ratio of 2.46 and a debt-to-equity ratio of 0.33. Neogen Co. has a fifty-two week low of $10.27 and a fifty-two week high of $18.58. The firm has a 50-day simple moving average of $12.08 and a 200-day simple moving average of $14.46.

Neogen (NASDAQ:NEOG) last issued its quarterly earnings results on Friday, January 10th. The company reported $0.11 earnings per share for the quarter, topping the consensus estimate of ($0.01) by $0.12. The firm had revenue of $231.30 million during the quarter, compared to the consensus estimate of $227.16 million. Neogen had a positive return on equity of 2.89% and a negative net margin of 52.12%. The company’s revenue for the quarter was up .7% on a year-over-year basis. During the same period last year, the company earned $0.11 earnings per share. Equities analysts forecast that Neogen Co. will post 0.38 EPS for the current year.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.